ArticleCell biochemistry and biophysics2026
Green Fabrication and Characterization of Copper Oxide Nanoparticles Using C. Gigantea Leaf Extract and Their ROS-Mediated Anticancer Activity Against A549 Lung Cancer Cells.
Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pharmacological properties of C. gigantea have been scientifically validated, making it evident the significance of this plant in both traditional and contemporary medicines. In the current investigation, CuO-NPs were synthesized using the green synthesis method with the leaf extract of C. gigantea and then its antineoplastic activities were determined against human lung carcinoma cells. The phytochemical analysis of the leaf extract of C. gigantea reveals the presence of several active chemicals, which include alkaloids, flavonoids, phenolics, saponins, terpenoids, and tannins. The antioxidant activity of the sample was analyzed using two standard methods, namely DPPH and FRAP assays. It is well documented that the sample exhibits remarkable free radicals scavenging activity. The characterization of the synthesized CuO-NPs was carried out based on its physicochemical properties. MTT assay was performed in order to study the anti-cancer activity of CuO-NPs. The outcome of the experiment indicated that there was a considerable decrease in viability of A549 cells. The cytotoxic mechanism of nanoparticles was examined using various methods, including DAPI staining, Rhodamine 123, and flow cytometry. It was observed that the cells experienced nuclear condensation, disruption of mitochondrial membrane potential, and induction of apoptosis. The main purpose of this research is to examine the use of a sustainable method for the synthesis of copper oxide nanoparticles (CuO-NPs) from C. gigantea leaves and to evaluate their physicochemical, antioxidant properties, and anticancer effects through ROS-induced mechanism against A549 human lung cancer cells.
Indexed as
Identifiers
42412309What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.